10:31:46 EDT Wed 24 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for March 19, 2015

2015-03-19 20:33 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange added a fraction to 667.09 Thursday. Andre Bergeron's halted capital pool shell, Woden Venture Capital Corp. (WOD), plans to acquire Agyl Inc. as its qualifying transaction.

Woden offers little information about its deal, and the little information it does offer is in French. After some searching, we found somebody who understands French, and we learned that Woden plans to close a $1.25-million private placement in connection with the QT. Agyl is a software company that designs mobile apps. It designed the Azra Network app, which provides Canadian electric car drivers with maps to the nearest charging stations and service stations. The drivers can also pay for a charge using their Azra Network app. Agyl also designed the AgylMD app, a billing management system for doctors in Quebec, some of whom apparently lose a significant portion of their income -- Agyl says up to 15 per cent, or even 30 per cent for new doctors -- due to the complexity of the medical billing process, as well as overlooked billings. The company says its app saves doctors from human error but it comes with a cost: $225 a month, plus tax. Woden does not say if its target generates much revenue, but that information will arrive when the shell submits a filing statement.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed